HAG
FLGT icon

HighPoint Advisor Group’s Fulgent Genetics FLGT Stock Holding History

HighPoint Advisor Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$483K Sell
5,365
-1,995
-27% -$181K 0.05% 316
2021
Q2 		$679K Sell
7,360
-2,435
-25% -$194K 0.07% 243
2021
Q1 		$837K Buy
9,795
+1,485
+18% +$153K 0.1% 172
2020
Q4 		$1.53M Buy
+8,310
New +$347K 0.19% 105

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

HighPoint Advisor Group's FLGT Position: Q3 2021 in Review

HighPoint Advisor Group reduced its Fulgent Genetics (FLGT) stake by 27% in Q3 2021, selling an estimated $181K and leaving 5,365 shares worth $483K. The position accounts for 0.05% of the portfolio, ranked #316.

HighPoint Advisor Group first reported a position in FLGT in Q4 2020 and has held it in 4 quarters since. The position peaked at $1.53M in Q4 2020. 268 funds tracked by Wall St. Rank hold FLGT as of Q3 2021.

  • HighPoint Advisor Group held 5,365 shares of Fulgent Genetics worth $483K as of Q3 2021.
  • HighPoint Advisor Group sold 1,995 Fulgent Genetics shares in Q3 2021, an estimated $181K.
  • Fulgent Genetics made up 0.05% of HighPoint Advisor Group's portfolio in Q3 2021, its #316 holding.
  • HighPoint Advisor Group first reported a position in Fulgent Genetics in Q4 2020 and has held it in 4 quarters since.
  • HighPoint Advisor Group's Fulgent Genetics position peaked at $1.53M in Q4 2020.
  • 268 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2021.

Based on HighPoint Advisor Group's 13F filing for Q3 2021, filed 15 Nov 2021.